Citizens Financial Group’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.95M Sell
283,183
-182,415
-39% -$4.86M 0.11% 138
2025
Q4
$11.6M Buy
465,598
+120,089
+35% +$3.03M 0.16% 115
2025
Q3
$8.8M Sell
345,509
-21,826
-6% -$539K 0.12% 139
2025
Q2
$8.9M Sell
367,335
-24,708
-6% -$576K 0.14% 130
2025
Q1
$9.93M Buy
392,043
+57,380
+17% +$1.5M 0.2% 102
2024
Q4
$8.88M Buy
334,663
+30,186
+10% +$819K 0.17% 106
2024
Q3
$8.81M Buy
304,477
+104,167
+52% +$3.04M 0.18% 107
2024
Q2
$5.6M Buy
200,310
+77,780
+63% +$2.14M 0.12% 132
2024
Q1
$3.4M Sell
122,530
-23,439
-16% -$650K 0.11% 124
2023
Q4
$4.2M Buy
145,969
+42,202
+41% +$1.28M 0.15% 119
2023
Q3
$3.44M Sell
103,767
-11,470
-10% -$406K 0.14% 110
2023
Q2
$4.23M Sell
115,237
-14,355
-11% -$559K 0.15% 114
2023
Q1
$5.29M Buy
129,592
+5,326
+4% +$230K 0.19% 104
2022
Q4
$6.37M Buy
124,266
+1,415
+1% +$67.8K 0.25% 92
2022
Q3
$5.38M Sell
122,851
-565
-0.5% -$27.5K 0.24% 91
2022
Q2
$6.47M Buy
123,416
+5,656
+5% +$288K 0.27% 81
2022
Q1
$6.1M Sell
117,760
-1,728
-1% -$89.7K 0.21% 92
2021
Q4
$6.95M Buy
119,488
+22
+0% +$1.09K 0.23% 90
2021
Q3
$5.14M Buy
119,466
+42,957
+56% +$1.9M 0.19% 96
2021
Q2
$3M Buy
76,509
+8,367
+12% +$325K 0.13% 116
2021
Q1
$2.47M Buy
68,142
+362
+0.5% +$12.9K 0.13% 113
2020
Q4
$2.5M Sell
67,780
-7,037
-9% -$258K 0.14% 108
2020
Q3
$2.6M Sell
74,817
-7,007
-9% -$246K 0.17% 102
2020
Q2
$2.54M Sell
81,824
-1,381
-2% -$46.9K 0.18% 100
2020
Q1
$2.58M Buy
83,205
+689
+0.8% +$23.5K 0.21% 94
2019
Q4
$3.07M Sell
82,516
-6,556
-7% -$234K 0.2% 96
2019
Q3
$3.04M Sell
89,072
-183,517
-67% -$6.67M 0.22% 92
2019
Q2
$11.2M Sell
272,589
-7,848
-3% -$312K 0.82% 41
2019
Q1
$11.3M Buy
280,437
+7,767
+3% +$311K 0.83% 38
2018
Q4
$11.3M Sell
272,670
-1,173
-0.4% -$48.7K 1.03% 28
2018
Q3
$11.4M Buy
273,843
+169,086
+161% +$6.51M 0.9% 35
2018
Q2
$3.61M Sell
104,757
-9,231
-8% -$315K 0.3% 83
2018
Q1
$3.84M Sell
113,988
-5,654
-5% -$194K 0.32% 79
2017
Q4
$4.11M Sell
119,642
-10,259
-8% -$350K 0.33% 76
2017
Q3
$4.4M Buy
129,901
+3,405
+3% +$109K 0.38% 79
2017
Q2
$4.03M Sell
126,496
-15,680
-11% -$494K 0.36% 83
2017
Q1
$4.62M Sell
142,176
-20,719
-13% -$653K 0.41% 78
2016
Q4
$5.02M Sell
162,895
-217,276
-57% -$6.63M 0.49% 73
2016
Q3
$12.2M Sell
380,171
-7,269
-2% -$243K 1.16% 19
2016
Q2
$12.9M Sell
387,440
-14,372
-4% -$459K 1.24% 15
2016
Q1
$11.3M Buy
401,812
+22,937
+6% +$655K 1.09% 24
2015
Q4
$11.9M Buy
+378,875
New +$11.9M 1.13% 21

Other funds holding PFE

Citizens Financial Group's PFE Position: Q1 2026 in Review

Citizens Financial Group reduced its Pfizer (PFE) stake by 39% in Q1 2026, selling an estimated $4.86M and leaving 283,183 shares worth $7.95M. The position accounts for 0.11% of the portfolio, ranked #138.

Citizens Financial Group first reported a position in PFE in Q4 2015 and has held it in 42 quarters since. The position peaked at $12.9M in Q2 2016. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Citizens Financial Group held 283,183 shares of Pfizer worth $7.95M as of Q1 2026.
  • Citizens Financial Group sold 182,415 Pfizer shares in Q1 2026, an estimated $4.86M.
  • Pfizer made up 0.11% of Citizens Financial Group's portfolio in Q1 2026, its #138 holding.
  • Citizens Financial Group first reported a position in Pfizer in Q4 2015 and has held it in 42 quarters since.
  • Citizens Financial Group's Pfizer position peaked at $12.9M in Q2 2016.
  • 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Citizens Financial Group's 13F filing for Q1 2026, filed 1 May 2026.